miRNA-126a plays important role in myoblast and endothelial cell interaction.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
12 09 2023
Historique:
received: 08 03 2023
accepted: 29 08 2023
medline: 14 9 2023
pubmed: 13 9 2023
entrez: 12 9 2023
Statut: epublish

Résumé

Muscle satellite cells (SCs) are stem cells and the main players in skeletal muscle reconstruction. Since satellite cells are located near or in direct contact with blood vessels their niche is formed, inter alia, by endothelial cells. The cross-talk between satellite cells and endothelial cells determines quiescence or proliferation of these cells. However, little is known about the role of miRNA in these interactions. In the present study we identified miRNA that were up-regulated in SC-derived myoblasts treated with stromal derived factor-1 (SDF-1) and/or down-regulated in cells in which the expression of CXCR4 or CXCR7, that is, SDF-1 receptors, was silenced. SDF-1 is one of the important regulators of cell migration, mobilization, skeletal muscle regeneration, and angiogenesis. We hypothesized that selected miRNAs affect SC-derived myoblast fate and interactions with endothelial cells. We showed that miR-126a-3p inhibited both, myoblast migration and fusion. Moreover, the levels of Cxcl12, encoding SDF-1 and Ackr3, encoding CXCR7, were reduced by miR-126a-3p mimic. Interestingly, the miR-126a-3p mimic significantly decreased the level of numerous factors involved in myogenesis and the miR-126a-5p mimic increased the level of Vefga. Importantly, the treatment of endothelial cells with medium conditioned by miR-126-5p mimic transfected SC-derived myoblasts promoted tubulogenesis.

Identifiants

pubmed: 37699959
doi: 10.1038/s41598-023-41626-z
pii: 10.1038/s41598-023-41626-z
pmc: PMC10497517
doi:

Substances chimiques

Fibrinogen 9001-32-5
MicroRNAs 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

15046

Informations de copyright

© 2023. Springer Nature Limited.

Références

Stem Cell Res Ther. 2018 Sep 27;9(1):258
pubmed: 30261919
Physiol Rev. 2013 Jan;93(1):23-67
pubmed: 23303905
Exp Ther Med. 2022 Feb;23(2):142
pubmed: 35069823
Semin Cell Dev Biol. 2020 Aug;104:93-104
pubmed: 32005567
Hum Mol Genet. 2010 Nov 1;19(21):4145-59
pubmed: 20705734
Results Probl Cell Differ. 2015;56:1-23
pubmed: 25344664
Mol Biol Cell. 2008 Mar;19(3):994-1006
pubmed: 18094043
Int J Clin Exp Pathol. 2018 Feb 01;11(2):1023-1030
pubmed: 31938197
J Cell Sci. 2021 Jun 15;134(12):
pubmed: 34137441
Nat Commun. 2021 Jan 29;12(1):692
pubmed: 33514709
J Cachexia Sarcopenia Muscle. 2016 Sep;7(4):483-96
pubmed: 27239402
Oncol Lett. 2015 Nov;10(5):2842-2848
pubmed: 26722251
Cardiovasc Res. 2012 Jun 1;94(3):400-7
pubmed: 22451511
Mol Ther Nucleic Acids. 2020 Oct 04;22:722-732
pubmed: 33230469
Dev Cell. 2008 Aug;15(2):272-84
pubmed: 18694566
Microvasc Res. 2022 May;141:104339
pubmed: 35151721
Biochem Biophys Res Commun. 2015 Aug 28;464(3):705-10
pubmed: 26166821
Cardiovasc Res. 2011 Dec 1;92(3):449-55
pubmed: 21856785
J Cell Mol Med. 2021 Jun 12;:
pubmed: 34117709
Cell Rep. 2014 Jun 26;7(6):1982-93
pubmed: 24882011
PLoS One. 2015 Jul 15;10(7):e0133074
pubmed: 26177288
Cell Stem Cell. 2018 Oct 4;23(4):530-543.e9
pubmed: 30290177
Dev Biol. 2018 Jan 15;433(2):200-209
pubmed: 28811217
Mol Ther. 2011 May;19(5):895-902
pubmed: 21364544
Invest Ophthalmol Vis Sci. 2019 Jan 2;60(1):294-303
pubmed: 30657854
Stem Cells. 2018 Mar;36(3):458-466
pubmed: 29230914
Eur J Cancer. 2013 Jul;49(11):2596-607
pubmed: 23583221
EMBO Mol Med. 2020 Dec 7;12(12):e12357
pubmed: 33210465
Stem Cell Res Ther. 2015 Mar 24;6:46
pubmed: 25890097
Med Res Arch. 2020 May;8(5):
pubmed: 34222652
Asian Pac J Cancer Prev. 2019 Jan 25;20(1):193-197
pubmed: 30678431
Mol Med Rep. 2018 Apr;17(4):5300-5305
pubmed: 29393458
PLoS Biol. 2020 Jul 14;18(7):e3000410
pubmed: 32663219
BMC Cancer. 2010 Oct 09;10:542
pubmed: 20932331
PLoS One. 2017 May 12;12(5):e0177516
pubmed: 28498863
Biol Cell. 2012 Dec;104(12):722-37
pubmed: 22978573
Genes Cancer. 2011 Dec;2(12):1134-8
pubmed: 22866204
Mol Biol Cell. 2007 Apr;18(4):1397-409
pubmed: 17287398
J Cell Mol Med. 2021 Feb;25(4):2148-2162
pubmed: 33350092
Cell Adh Migr. 2017 Jul 4;11(4):384-398
pubmed: 27736296

Auteurs

Bartosz Mierzejewski (B)

Department of Cytology, Faculty of Biology, University of Warsaw, Miecznikowa 1 St, 02-096, Warszawa, Poland.

Maria Anna Ciemerych (MA)

Department of Cytology, Faculty of Biology, University of Warsaw, Miecznikowa 1 St, 02-096, Warszawa, Poland.

Wladyslawa Streminska (W)

Department of Cytology, Faculty of Biology, University of Warsaw, Miecznikowa 1 St, 02-096, Warszawa, Poland.

Katarzyna Janczyk-Ilach (K)

Department of Cytology, Faculty of Biology, University of Warsaw, Miecznikowa 1 St, 02-096, Warszawa, Poland.

Edyta Brzoska (E)

Department of Cytology, Faculty of Biology, University of Warsaw, Miecznikowa 1 St, 02-096, Warszawa, Poland. e.brzoska-wojt@uw.edu.pl.

Articles similaires

Humans RNA, Circular Exosomes Cell Proliferation Epithelial-Mesenchymal Transition
Curcumin Spinal Cord Injuries Humans Animals Neural Stem Cells

The significance of miR-124 in the diagnosis and prognosis of glioma: A systematic review.

Elham Ghasemi, Mahdieh Mondanizadeh, Amir Almasi-Hashiani et al.
1.00
Humans MicroRNAs Glioma Prognosis Biomarkers, Tumor

Classifications MeSH